This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Umicore Sa Ord New
2/14/2025
Hello and welcome to the Umicore Full Year 2024 results. My name is Sadiq and I will be your coordinator for today's event. Please note, this call is being recorded and for the duration of the call, your lines will be on listen-only mode. However, you will have the opportunity to ask questions at the end of the call. This can be done by pressing star 1 on your telephone keypad to register your question. If you require assistance at any point, please press star zero and you will be connected to an operator. Today, we have Bud Saab, CEO, and once before on CFO as your presenters. I will now hand you over to your host, Bud Saab, to begin today's conference. Thank you.
Hello, good morning, everyone, and welcome to our full year results 2024 call. So today we have the following agenda for you available. First of all, we're going to look at some of the key figures and full year highlights. Then I'll go in a bit more of a business review. Juanos will come back with the financial review. Then I'll return with the outlook 2025. We'll wrap it up and then I look forward on the Q&A together with you. So let's have a look at the highlights of 2024. So revenues for the group came in at 3.5 billion euro. We had still an EBITDA of €763 million for the year. EBITDA margin 22%. Still a strong operational cash flow of €384 million. CAPEX came in at €555 million. Well below the new target we set of €650 million at the mid of the year. And there we said we were going to come in below that €650 million. We came in at €555 million. We have a return on capital of 12.3%. and a leverage ratio of 1.9 roughly. Now, if I have a first glance at our foundation businesses, and that I really, really would like to highlight that we have here a strong and robust performance of the foundation business. In catalysis, we are publishing EBITDA margins close to 26%, return on capital more than 40%, despite a slower internal combustion engine market. For recycling, Return on capital close to 80%.
EBITDA margins of 36%.
And here we have seen lower revenues in the recycling segment, but I will come to that later on. Specialty materials. EBITDA margin came in below 20% and return on capital of 9%. This is not where we want to be. And this is mainly related to cobalt and specialty materials, on which I will give a bit more color also later on. Now, if we then look, of course, at battery materials. And this is a business on which we already exchanged quite a bit over the last quarters. And this business, as you all know, is characterized by a slowdown in demand for electric vehicles. And this also has a reflection on the ramp up of our customers and the volume development at Umicore. Now, as you all know, we have the strategic review ongoing and we're finalizing that one. And I really look forward to exchanging with you on these key messages, of course, in the upcoming Capital Markets Day in end of March. In the meanwhile, not awaiting, of course, the CMD updates, we have been targeting on our CapEx. And these came in 35% lower year on year, And this excludes still an equity contribution of €175 million to our joint venture with IronWay with its specific guardrails, of course, coming with that joint venture. Now, we also announced that we're going to pause the battery materials plant construction in Canada. And I'm also, of course, pleased to share that we were successful in integrating these customer contracts in our plant in Korea. So always in the spirit of filling capacity utilization in line with our customer commitments. Now we also have been realigning our operations. This of course, reflecting the base, the slower ramp up of our customer. We have adjusted our volume projections and we are focusing with our CapEx expansions really on the existing footprint. So MISA and Korea, that's where the CapEx is going. Next, of course, the standard maintenance topics that we foresee for the business. Now, if you look at the 2024 adjusted EBITDA for battery materials, we gave you an updated guidance at the mid-year that we would come in close to break even per year end. And that is also what we see for the business now at the close of the year. Of course, I also would like to come back on the very painful 1.6 billion impairments which we had to take in H1. We all know that this is not where we want to be, but we will continue to focus on that value recovery for this business. Now, at group level, of course, we did not just focus on battery materials. We have been significantly stepping up our efficiency and cost-saving measures across the group. We accelerated even more in the second half of the year, and we came in with 100 million EBITDA on efficiency and value-based initiatives that realized in this 100 million EBITDA euro EBITDA well ahead of the 70 million targets we had put for ourselves. Now, transiting to the dividends, we know that the environment around us at this point in time remains uncertain. We have a delayed ramp up with our customers and also our earnings as a consequence have dropped significantly for 2024. In that context, the supervisory board proposes a cross annual dividend of 50 euro per share, which is 25 cents on top of the earlier paid interim dividends over summer. Now, this still represents a payout ratio of 47% on the current net earnings per share. The supervisory board also intends to reset the annual baseline for the dividends at 50 cents per share, and that's well in line with the ongoing policy of a stable or rising dividends.
Let me now zoom in a bit more on the different business segments. Battery materials.
So we clearly have a decrease in revenues and EBITDA for battery materials compared to the previous years. And let me start off with the revenues. We know that we have lower CAM sales volumes. We discussed already on that before. As well, we have lower refining income. And this is mainly reflecting the slowdown in EV sales and also the slower ramp up of our customers and the tailing off of legacy contracts faster than we initially expected. Of course, also in 2023, there was a non-recurring lithium effect, which was sizable, which is affecting the year on year comparison. If we look at the EBITDA, that also was a substantial non-recurring effect in 2023, which we will not have for 2024. And we have been able to partially offset these drop in EBITDA with lower overheads and a positive one-off of roughly €40 million in 2024. CAPEX came in at €307 million, well below 2023. And I repeat myself, focused on the finishing of the plant in Europe, as well as Korea to serve against our customer commitments. And we paused, of course, the plant in Canada. If we now go to catalysis. Now, let us first have a look at the market for catalysis. And there we see that if we look at 2023, there was roughly 79 million ICE vehicles sold. And if you then look to the year 2024, we do see a reduction of close to 3 million vehicles, and especially in the second half of the year. We exchanged on that also during the half years, and we anticipated that in our forecast for the second half. And so basically predictions came in according to what we expected at that point in time. Now, let me give some more color on the specific sub markets. Let me start off with China. China was roughly stable in terms of IC production, but underlying, there was a significant shift in that market. We clearly see that local OEMs, Chinese OEMs are taking more market share at the expense of Western OEMs. Classically, Umicore has grown with Western OEMs in the Chinese markets. But in the last two, three years, we also heavily focused on gaining market share with the local OEMs. We were quite successful with this. But despite that, we still lost some market share in China. But again, good progressions with the local OEMs. And we remain positive about this market going into 2025. On North America, a small contraction of the markets. And there we lost market share mainly because of an unfavorable customer mix. If we then go to Europe, it's the opposite. There the market lost close to 7%, but the overall market share grew for this segment. In Japan and Korea, we performed well, but the market in general dropped by 6%. We had strong business in South America as well, where also our market position remains very strong. If we then look at it, hdd business we do see a weaker economy being reflected in the hdd numbers in europe but also in china and in china more specifically we also see much more cng trucks being sold at the expense of hdd production so this is also an underlying volume effect that plays in our business for catalysis now if you now look at the number set let me talk first of catalysis as a whole and in catalysis as a whole We also have impacts, of course, of an exposure to the PGM prices. And we are very clear that some of the favorable PGM price lock-in effects that we have are tailing off across this business group. If I now zoom in a bit on the different underlying business groups here as well, for automotive catalyst, I must say we had an outstanding performance, which is really reflecting the impact of our structural measures towards efficiency, and value orientation. Also, our footprint optimization and our focus on having selective R&D and reduced overhead spend is really paying off, but also the general culture that we have embedded in this business unit is really showing paying off results with really impressive results, I would say. The fuel cells and stationary catalyst, there we had basically two elements. On the one hand, the stationary catalyst business performed really strong. While the fuel cell business, we saw a slower 2024, mainly related to volumes being lower in China at the back of a subsidy scheme that was not yet into effect. The construction of a fuel cell plant, so the PEM fuel cell plant in Changshu in Shanghai, is progressing well, well within budget, well within time, and we expect this to become operational in early 2026. And precious metals chemistry, there, the main impact on the results was basically also the reduction in that PGM price environment, but we saw a stable sales for our HOC, so our homogeneous catalyst business. Now let's have a look at recycling. For recycling, there are two main drivers here. First of all, we have to highlight that there's an unfavorable trading context, especially for the precious metals management environment, especially for rhodium and palladium. If you then look, for instance, at precious metals refining, they're the main, in fact, place around volumes. So we had the plant shut down in the first half of the year, and we had an operational smelter issue in the second half of the year affecting the volumes. Smelter is, again, of course, well up and running and processing well. If you look at the gin business, there I would say revenues were stable. and overall a good business intake and we're happy with the performance of this business for the year. Now let's have a look at specialty materials. Specialty materials is the first time that we report full results on it. And here we see that the performance of specialty materials was slightly worse than last year and can mainly be attributed to the business unit cobalt and specialty materials, which is the heavyweight also in that group, where we see a weak cobalt and nickel markets out there. And this has, of course, led to competitive pressure. And in terms of optic materials, revenues were slightly higher. So we continue to grow there. We have good volumes for the germanium substrates and the recycling business and a good performance of the infrared applications. Earnings slightly lower because we had some production challenges in the infrared solutions which are being tackled and where we're making, again, good progress for the year 2025. And MDS, an all-in-all stable market, although that the underlying product mix was changing, but a good performance for this business unit as well. So, Wanhas, let me now pass the word to you for more deep dive in the financials. Thank you, Bart, and good morning to you all.
As shared earlier by Bart in 24, we faced substantial headwinds in different markets. We succeeded in implementing sizable cash saving measures to offset some of these headwinds. When we look at the revenues, the revenues decreased with 11% year over year and amounted to 3.5 billion euros for 24. The decrease is primarily reflecting the slowdown in electrification in battery materials and the global decline in light-duty and heavy-duty vehicle production in catalysis. In recycling, revenues were affected by the maintenance shutdown and the less favorable PGM trading environment. Revenues in catalysis and recycling were also impacted by the lower PGM price environment, but our hedging strategy continued to create a substantial support versus spot prices, in particular for rhodium and palladium. The adjusted EBITDA amounted to 763 million euros, which is 209 million euros below previous year. In battery materials, volumes weakened in the second half of the year, and the year-over-year comparison was also impacted by the lower level of one-offs compared to last year. Following the lower than expected growth of electric vehicles and the delayed ramp-up in battery materials, we immediately initiated additional measures to adjust our cost basis. This included a strict review and control of all group-wide spending, a hiring freeze, and additional right-sizing of the group. As a result, we achieved over 100 million euros in efficiency gains across the group, which is substantially higher than our initial target of 70 million euros for 24. In catalysis, quality of earnings further increased, despite volumes and PGM prices. EBITDA remains roughly flat, which is another impressive performance versus last year's record result in a maturing market. In corporate, net operating expenses improved by almost 10%, again reflecting the efficiency measures taken. And the EBITDA margin for the group remains strong at 22%. Now, moving to the consolidated P&L. As you can see, depreciations and amortizations decreased to a level of 285 million euros due to the impairment in battery materials. Adjusted EBIT amounted to 478 million euros versus 674 million last year. Adjusted net finance cost slightly decreased to 108 million euros. The interest income on our cash deposits went up while the cost of gross debt remained stable. The average cost of gross debt amounted to 3.2% and is expected to remain well under control given the long-term debt maturities and the high share of fixed rate debts. The adjusted tax charge decreased to €109 million following the lower adjusted taxable profit. Due to increased provisioning for uncertain tax positions, the adjusted effective tax rate increased to 29% versus roughly 22% last year. The adjusted net profit group share amounted to €255 million, which resulted in an adjusted EPS of €1.06. The net result was impacted by adjustments to EBITDA of 1.8 billion euros, which is mainly due to the 1.6 billion euro non-cash impairment and write-down in battery materials. As a consequence, the net result group share amounted to minus 1.48 billion euros. Now moving to the consolidated balance sheet. As you can see, property, plant and equipment, inventories and equity were substantially impacted by the impairment in battery materials. Here I would like to highlight the strong liquidity of the group, with a cash position of 2 billion euros. The average deposit rate increased to 3.6%, which is exceeding our costs of debt. The gross financial debt increased to 3.4 billion euros versus 2.6 billion last year. I will come back to the debt movements later in this presentation. The equity of the group amounts to 1.9 billion euros, And against the net financial debt of 1.4 billion euros, net gearing ratio remains balanced at 42.6%. Now, on this slide, we show the breakdown in the evolution of the free operating cash flow. The free operating cash flow for 24 remained strong at 384 million euros. We managed to reduce networking capital needs with 392 million euros across the different businesses, thanks to a strong focus on timely collection payment terms, and inventory management. We reduced CAPEX with €303 million, or one-third versus previous year. CAPEX, including capitalized development expenses, amounted to €582 million. And as Bart mentioned earlier, this is well below the guidance that we shared during the half-year results. The reduction in CAPEX is primarily driven by battery materials, where we passed the investment in Canada, and where we also maintained the investments in Europe and Korea in line with the long-term commercial agreements. Now, looking at the net cash flow movements. As you can see in this bridge, the free operating cash flow of €384 million did not fully cover the cash out related to taxes and financing, the equity contribution of €175 million to IronWay and dividends. As a result, the net financial debt increased with €159 million and amounted to €1.4 billion. The leverage ratio increased to 1.87 times last 12 months adjusted EBITDA. Now, we continue to be committed to a strong balance sheet going forward. With the delayed ramp-up in bathroom deals, we accelerated various initiatives to further reduce cash out. In 2024, the efficiency measures contributed over €100 million, CapEx was reduced by 35%, and working capital needs were reduced to €392 million. For 2025, we target to generate an additional €100 million of efficiency savings, which come on top of the savings of 2024. And we also anticipate to reduce CAPEX with another 20%, mainly in battery materials. For IronWay, both partners continue to fund the investment through equity injections until the project financing is in place. At the start of 25, Umicore injected 250 million euros out of a total planned contribution of 400 million for the full year. Both partners are targeting to have the non-recourse debt financing in place in the second half of 26. Now, the combination of all these measures support the balance sheet and ensure that the leverage will remain in investment-grade territory. For 2025, we expect that the leverage ratio will increase towards the level of 2.5 times. Now, as I mentioned earlier, the group has a strong liquidity with €2 billion cash on balance. And on top of that, over €1 billion of committed and undrawn long-term credit facilities. In 24 we successfully raised 750 million euros of long-term debt with the European Investment Bank and a US private placement. And as you can see in this graph, the debt maturity profile is well spread with an average maturity of 5.6 years after repayment of the convertible bond in June 25. The debt that we need to refinance in 25 and 26 is well covered by the current cash position. Now, Finally, I would like to highlight that in 24, we continue to lock in future strategic metal exposures through forward contracts. Over the past six months, we increased forward metal hedges in particular for platinum until 28, but also for rhodium, palladium and silver in 28. And we also initiated the first hedges for 29. The group also manages a portion of its energy price through forward contracts. Today, we have hedged more than 75% of the expected European electricity and natural gas consumption until 2027. And thanks to this hedging approach, we protect future earnings from price volatility, but we also increase the visibility on our future cash flows. Now, before heading back to Bart for the outlook, I would like to repeat that we have taken a wide range of measures to improve the financial performance across the group and to increase the cash generation across the group. And this will help us to maintain Europe's balance sheet. Thank you.
Yes, thank you. And let's now have an outlook, a look at the outlook for 2025. So in general, we should say, of course, that there's still a limited visibility in the markets. I mean, still a lot of elements are in flux. And of course, we will continue our focus on maintaining resilience, adaptability, and of course, the efficiency and value focused initiatives I talked about earlier. So we are guiding early in the year, despite all these uncertainties, we're guiding early in the year that we will have group earnings for the adjusted EBITDA between 720 and 780 million euro. But I want to be very explicit on this, and that's also why the disclaimer is there. This is not taking into account any market effects or conditions related to geopolitical tensions or tariffs, which could come into effect in the current markets. Now, for batting materials, we anticipate that the adjusted EBITDA will be there in the range of last year, yet without the one of 2024. For catalysis, earnings are expected to be around the outstanding performance of the previous years. Recycling earnings will be below 2024, as some of these favorable hedging hedges, PGM hedges are tailing off. And especially materials will be slightly ahead of last year's earnings. We do anticipate that our corporate costs will be down compared to 2024. We reduce our capex by another 20% and we are upping our efficiency goal from the initial goal accumulated for 2025 of 100 million. We upped that to 200 million and this is well integrated into the guidance we give at group level, so the 720 to the 780 million euro.
Now, wrapping everything a bit up.
Now, it's fair to say that 2024 was a sobering and intense year for Umicore, its shareholders, but also its employees. So it was a year marked by significant headwinds. and during which we had to take difficult decisions and also had to impair a big part of our battery materials business. Despite this challenging context and the slowdown of the EV growth, we really had a solid performance in our foundation businesses. We have taken decisive actions in capital discipline, in efficiency and cost measures, and we are committed to keep a solid balance sheet. We are determined to lay the groundwork for the future, and I'm looking very much forward on exchanging with you on this during our capital markets day on March 27th in London. I continue to believe in the value creation of this great group. We have great societal underlying trends that strengthen our position going forward. And once again, I'm now open to the Q&A and very much looking forward to exchange on a midterm future during the capital markets upcoming end of March.
Thank you very much. Ladies and gentlemen, as a reminder, if you would like to ask a question, please press star 1 on your telephone keypad. We will take our first questions from Randolph or from Citi. Your line is open. Please go ahead.
Hi. Thanks for taking the question. It's just one on Iron Way. Can you give a bit of an update on the program there, the timeline, and where you expect minimum returns to come on the equity injections? Thank you.
Good morning, Randolph. So looking at IronWay, we are well on track. So looking at the capital injections, this is where the capital injections are somewhat more front-loaded, because the project financing is a process that is lengthy and demanding, so it does take time to put this into place. We have confirmation from banks that this is a very bankable project, so that gives us the confidence, and that's also where both partners are targeting it. to have the project financing in place as from the second half of 26. Looking at the return targets, at the same time, we cannot be explicit or share too much commercial details on this, but we continue to have trust in this overall relationship.
Yeah, and I would add to that, Juan, of course, that value creation is always a guiding principle that we have here at Umicore, so also for the IMHL's venture.
Okay, thank you.
Thank you. We will take our next questions from Chetan Udeshi from JP Morgan. Your line is open. Please go ahead.
Yeah, hi, morning. I just wanted to maybe first discuss what are the implications on Umicore from any trade tariffs or import tariffs, say on metals, etc. How are you Or how might you be directly and indirectly impacted from that? The other question is, I'm sorry to be a bit blunt here, but I appreciate you are cutting capex in battery materials, but it still implies that you are probably going to spend 200 million capex in 2025 on top of 400 million that you are aiming to contribute to the IronWave JV. I mean, your EBITDA in this business is zero. Last year was zero. I'm just curious, where is all this? I mean, I understand IronWave, but where is that 200 million on battery materials being spent? Your facilities are predominantly underutilized everywhere. So I'm just curious why the CapEx is not even down more than what you are guiding to.
Yeah, thank you for the questions, Chitram. I highly appreciate it. So first on, of course, trade and geopolitical. That's, of course, a very big question and not an easy one to answer. We have seen, for instance, just the movement in steel and aluminium based on certain tariff announcements. We know that, for instance, there's also threats against Mexico and Canada. So very difficult to predict how things will move because First of all, how will the overall competitive landscape move in such a way? How will metal flows be impacted? But here we really have to focus on our core strengths. And our core strength is that we have an agile footprint from which we can supply customers. We also have a diversified supply basis. So if any countries would be maybe struck or hit with certain tariffs for PGMs, then we might have optionalities to supply from a different country. But again, Putting here a number, then I would go really in the territory of pure speculation because I have no clue what the legislators have in mind and what potential reactions to some decisions might be from other countries. So I'm sure you appreciate that. And that's also why we had the disclaimer really on the outlook because, I mean, bets are off there, I would say. Now, if you look to the CapEx and IronWay, I mean, I'll tackle IronWay first. I said that again, we have strong guardrails in these contracts. Value creation is is what we focus on as Umicore. So that's really an investment in a partnership. On the CapEx for battery materials for 2025, well, first of all, let me go to Canada in the sense that we decided not to continue with Canada to really save significantly on CapEx because there we would have to spend big if we would have continued with that project. The consequence, of course, is that we had to repatriate the customer contract into Korea. And that's really a strong proof point. And it's really a success that we were able to do that. But in order to deliver against this future customer commitments, we do have to de-bottleneck the plant in Canada, sorry, in Korea. And that's where, of course, CapEx is going. And indeed, we're also still having some CapEx going into Europe to finish off the current footprint against our customer commitments. But let's say the longer term profile and inputs, I will be glad to discuss that also, of course, end of March at the CMD GDEM.
Maybe if I can just still add to the trade tariffs and potential threat of trade tariffs. We have been running a program in the company in order to map the different flows. And this is also where we see having the footprint, the global footprint in catalysis, that this can create options also to circumvent or to reduce or mitigate some of the impact. Same for the precious metal flows. Also here, we have a global setup where we can source and deliver out of different regions. And this can also help to mitigate potential impact if certain measures would be taken. That's right, Juanes.
Can I follow up on volumes that you were talking about, battery materials? Can you discuss where are we in terms of volumes now? Because you had talked about 18-month delay. Is that delay getting longer? Because I'm just curious. You are starting to de-bottleneck the Korean plant. when frankly we don't even have any volumes. I'm just curious, why is there a disconnect, to be honest?
Yeah, I mean, not any volume is probably an absolute statement that you make there, Chetan. So, I mean, we also hinted during the mid-year results that we do have capacity utilization in Korea and that it's moving to a pretty good level in the years to come. That's what we clearly indicated. But on the volume picture, indeed, the outlook remains mixed for the time being because EV sales remains somewhat slow at this point in time. Now, at the same time, we always talked also about the strong contractual guardrails that we have. Basically, we also have the take or pay provisions, which will protect our EBITDA profile. So that's where we stand. Can there be a longer period than 18 months in the ramp-up? Possibly, difficult to say because the outlook remains mixed, but again, we have put these strong contracts in place for situations like this, and we will utilize these contracts. Okay, thank you.
Thank you, Chetan. Thank you. We will take our next questions from Jeff Hare from UBS. Your line is open. Please go ahead.
Yeah, good morning. I just wonder if I could focus in on the battery materials business and then a question on the cash costs for the restructuring. So first of all, on battery materials, when you were looking at all of the contracts that you have and where you wanted to place CapEx, was there any time there ever a consideration of actually exiting some of the larger contracts that you have so that you can actually save more CapEx? And then secondly, with the increase in the IronWay equity contribution, do you expect to create positive free cash flow in 2025? And then finally, could you just update us on what the cash costs are related to the additional savings that you expect to get in 2025?
Okay, let me talk about, let me take the customer part, and then you take the second part.
Well, Joff, I mean, we have strong contractual contracts, so we have these take-off pays in there, but we also, of course, have customer commitments and we are building against these customer commitments. I also indicated at the mid-year that while we still see that progression, of course, on that volume curve for the existing customer portfolio that we have, that we continue also to look in further customer diversification. There's a continued interest in Europe also by Asian players. So I continue to believe in that differentiating asset that we have here in Europe. So one is maybe you can go to the other two.
Yeah. So looking at the free cash flow for the group in 25, looking at the different components. So we have the EBITDA range or the guidance that we give between 720 and 780. We have the capex where we say below 450. We have the equity contribution of 400. So free cash flow. will be negative, I would say. And this is also where we expect the net debt to increase and where the leverage will also increase towards the level of 2.5. Now, looking at the cash cost restructuring, this is what we have provided for. So what we have included in the provision for 24 is, I would say, roughly 70 million, which is linked to the restructuring in catalysis, which we announced in the first half. but also linked to the right-sizing of the group, which we announced in the second half of the year. And this will add then into the cash cost savings for 2025, where we say that we are aiming to generate another €100 million savings on top of the €100 million that we have generated in 2024.
Yes, and indeed on this restructuring, especially also in Belgium, I think we made great progress and had a very good and constructive dialogue with our social partners. I think we have panned out the right supporting measures for our customers, and now we are actually in the implementation phase of these measures, so we should indeed see that effect in 2025.
Just to clarify that there is no further cash cost related to the cost savings program that you've got in 2025. That was all taken in 2024, yeah?
That is correct.
Thank you.
Thank you. As a reminder, if you'd like to ask a question, please signal by pressing star 1 on your telephone keypad. We will move to the next questions from Tristan Lamotte from Deutsche Bank. Your line is open. Please go ahead.
Hi. Thanks for taking my questions. I've got three. The first is, what are the remaining restructuring costs on the cost programs and how will that impact cash? The second is, You talked about an impact from metal hedges rolling off in 2025. Given your hedges are kind of up to four years, do you expect to have another impact in 2026 again? And then third question on battery materials, just wondering with the take or pay contracts, so kind of at the minimum, what kind of EBITDA could you do in 2026? Thanks a lot.
Okay, so looking at the restructuring, just to be clear, so we provided for the restructuring amounts, but the cash out will be in the year of 25, and this is what they refer to the 70 millilitre. Then looking at the metal hedges, so in 24, we had filler substantial support looking at metal hedges, in particular for palladium and rhodium, and this is where we see a roll-off in 25, and there will be a further roll-off in 26. And looking at the last question, take or pay.
Yeah, I can take that one on the take or pay. I mean, in 2025, some take or pay will be in effect for the year. And we also intend to include this as part of our EBITDA because it's an integral part of our business and these contracts. But we're not going to guide for 2026 on this number. And we can discuss more at the CMD end of March.
Thanks a lot.
Thank you.
Thank you. We will take our final questions from Charles Bentley from Jefferies. Your line is open. Please go ahead.
Thanks so much for taking my question. It was just a simple one, just on the Ionway investment. If I remember correctly, it was $2.9 billion of total funding, of which half was meant to come from debt, and then half from each of the partners, so $725 million total. That would suggest that by the end of this year, there's still 200 million remaining. Is that the right number? And is the kind of debt to equity components of the funding structure, is that unchanged, or is there any risk to that? Thank you.
Yeah. So, board partners still target to fund at least 50% of the cash needs through debt financing, so that remains. Looking at the projections on the equity contributions, again, this is where we are a bit more front-loaded and where for 2025, we expect another 400 million versus the 250 million that year-to-date we already contributed, looking at past years. And then the outlook for 2026, this is where it will depend on the timing of the effective project financing. I think overall, looking at the overall CapEx budget, this is, of course, something that is commercially sensitive. that we cannot asset share, but at the same time, there's also some inflation that plays a role looking at that project.
Yeah.
So, I mean, one is maybe to the point. Indeed, I mean, the contract was closed, let's say, in the 2021 period. So, indeed, we do see some inflation on this project, like many other projects, of course, within Europe, right? But again, let me guide again that we work with committed waves for this project. And of course, for these projects or this kind of setup, we do have strong guardrails. So our commitment and belief in this joint venture is completely intact, Charles.
Just for clarification, so looking at the equity contributions, so looking at the year 2020, 2023 and 2024, we had 250 million of equity contribution. For this year, we expect to have up to 400 million of equity contribution.
Thanks very much, Cass. Thanks, Charles.
That was the last questions for today. I will now hand over back to Mr. Sepp for any closing remarks. Please go ahead, sir.
Yes, thank you for attending the 2024 full year results. As said before, it was a sobering and intense year, not an easy year for our shareholders, also for here, for us at Umicore. But I really would like to look forward and engage with you on the future of this great company that we have at the Capital Markets Day at the end of March. So see you all in London and looking forward to that exchange. Have a wonderful day.
Thank you for joining today's call. You may now disconnect